Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Equity Bottom-Up

<div><ul><li>Meet the CEO. Jagi Gill began his career as an Assistant Professor of Neurology at Mayo Clinic, embracing two principles that guide him today: relentless innovation and putting patients first.</li><li>He later joined Boston Scientific, gaining experience in neurostimulation, and Advanced Bionics, where he discovered the energy of startups. </li><li>He went on to found Tenex Health, a pioneer in tendon pain treatment, before returning to neurostimulation as founder and CEO of Apyron.</li></ul></div>

Meet the CEO. Jagi Gill began his career as an Assistant Professor of Neurology at Mayo Clinic, embracing two principles that guide him today: relentless innovation and putting patients first.He later joined Boston Scientific, gaining experience in neurostimulation, and Advanced Bionics, where he discovered the energy of startups. He went on to found Tenex Health, a pioneer in tendon pain treatment, before returning to neurostimulation as founder and CEO of Apyron.

How Apyron's Neurostimulation Solution Breaks the Chronic Pain Barrier

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Apyron (APY123D US)

How Apyron's Neurostimulation Solution Breaks the Chronic Pain Barrier

Meet the CEO. Jagi Gill began his career as an Assistant Professor of Neurology at Mayo Clinic, embracing two principles that guide him today:...

Water Tower Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)